Category: Oncology/Hematology
Global Oncology/Hematology
-
Global Non-melanoma Skin Cancer Market 2024-2028
... forecast period. The report on the non-melanoma skin cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Cancer Diagnostics Market by Diagnostic Type (Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, and Other Diagnostic Types), Application (Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, and Other Applications), Regional Outlook– Global Forecast up to 2030
... Other Applications), Regional Outlook– Global Forecast up to 2030 We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to ... Read More
-
Point of Care Diagnostics Market By Product: Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others; By End User: Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-testing, Regional Outlook - Global Forecast up to 2030
... and Homecare/Self-testing, Regional Outlook - Global Forecast up to 2030 We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content ... Read More
-
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
... are designed to enhance the immune response or modulate the immune system's regulatory mechanisms, thereby enabling the body to effectively target and eliminate disease-causing agents or cellsThe immunotherapy drugs market is projected to grow from ... Read More
-
Global Core Clinical Molecular Diagnostics Market Size study, by Product Type (Instruments, Reagents, Software & Services), by Technique (PCR, Nucleic Acid Sequencing, Fluorescence In Situ Hybridization (FISH), Others), by Application (Infectious Diseases, Genetic Disorders, Cancer Screening, Others), and Regional Forecasts 2022-2032
... Screening, Others), and Regional Forecasts 2022-2032 The Global Core Clinical Molecular Diagnostics Market is valued at approximately USD 5.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Breast Cancer Liquid Biopsy Market 2024-2028
... 18.06% during the forecast period. The report on the breast cancer liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Global Oncology Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Cancer Diagnostics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market 2024-2028
... on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Non-small Cell Lung Cancer Drugs Market 2024-2028
... The report on the non-small cell lung cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Hairy Cell Leukemia Therapeutics Market 2024-2028
... on the hairy cell leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Cancer Cachexia Global Market Report 2024
... Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA Cancer Cachexia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024
... Assays3) By Therapeutic Area: Lung Cancer; Breast Cancer; MelanomaCovering: Thermo Fisher Scientific Inc.; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; WuXi AppTec Co Ltd. Cancer Immunotherapy Drug Discovery Outsourcing Global Market ... Read More
-
Antisense And RNAi Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Cardiometabolic & Renal Disorders, Cancer, Respiratory Disorders, Skin Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other), By Region and Competition, 2019-2029F
... Disorders, Infectious Diseases), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other), By Region and Competition, 2019-2029F Global Antisense And RNAi Therapeutics Market was valued at USD 4.57 billion in 2023 and is ... Read More
-
Global Multiple Myeloma Drugs Market 2024-2028
... multiple myeloma drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Cancer Immunotherapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Growth & Trends The global autologous cell therapy market size is expected to reach USD 17.97 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
-
Prescription Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
Research Assistance
